EBS vs TECH
Emergent Biosolutions Inc (EBS) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
EBS currently screens at market cap $416.4M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the EBS and TECH stock pages for the full models.
Not investment advice.